Skip to main content
Top
Published in: BMC Neurology 1/2012

Open Access 01-12-2012 | Research article

Oxidative stress markers are associated to vascular recurrence in non-cardioembolic stroke patients non-treated with statins

Authors: David Brea, Jaume Roquer, Joaquín Serena, Tomás Segura, José Castillo

Published in: BMC Neurology | Issue 1/2012

Login to get access

Abstract

Background

Since atherogenesis is related to oxidative stress, our objective was to study the association of oxidative stress markers with the vascular recurrence in non-cardioembolic stroke.

Methods

Atherosclerotic and oxidative stress markers were evaluated on admission, in 477 patients suffering from a first non-cardioembolic stroke. Patients were followed at 6 and 12 months after inclusion, recording cardiovascular events. As markers of endothelial oxidative stress we used oxidized LDL, Cu/Zn superoxide dismutase and 8-OH deoxiguanosine. 136 patients were being treated with statins at the moment of serum samples acquisition.

Results

Patients who suffered vascular recurrence or vascular-origin death had higher levels of 8-OHDG (40.06±24.70vs33.11±15.18;p=0.003). We also found associations between vascular recurrence or vascular origin death and Cu/ZnSOD (OR,1.02; 95%CI,1.00-1.03;p=0.0001) and 8-OHDG (OR,1.12;95%CI,1.08-1.16;p<0.0001) in a subgroup of 333 patients that were not in treatment with statins on admission. We also found associations between 8-OHDG and intima media thickness (IMT) (OR,1.13;95%CI,1.09-1.16;p<0.0001), presence of ipsilatieral stenosis≥50% (OR,1.03;95%CI1.00-1.05;p=0.007) and other atherosclerotic plaque characteristics.

Conclusions

Specific oxidative stress markers were found to be markers of atherosclerosis plaque types and vascular recurrence in non-statins treated patients at admission.
Appendix
Available only for authorised users
Literature
1.
go back to reference Brassard A: Identification of patients at risk of ischemic events for long-term secondary prevention. J Am Acad Nurse Pract. 2009, 21: 677-689. 10.1111/j.1745-7599.2009.00444.x.CrossRefPubMed Brassard A: Identification of patients at risk of ischemic events for long-term secondary prevention. J Am Acad Nurse Pract. 2009, 21: 677-689. 10.1111/j.1745-7599.2009.00444.x.CrossRefPubMed
2.
go back to reference Viles-Gonzalez JF, Fuster V, Badimon JJ: Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. Eur Heart J. 2004, 25: 1197-1207. 10.1016/j.ehj.2004.03.011.CrossRefPubMed Viles-Gonzalez JF, Fuster V, Badimon JJ: Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. Eur Heart J. 2004, 25: 1197-1207. 10.1016/j.ehj.2004.03.011.CrossRefPubMed
3.
go back to reference Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, et al: Heart disease and stroke statistics–2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007, 115: e69-171. 10.1161/CIRCULATIONAHA.106.179918.CrossRefPubMed Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, et al: Heart disease and stroke statistics–2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007, 115: e69-171. 10.1161/CIRCULATIONAHA.106.179918.CrossRefPubMed
4.
go back to reference Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow C: Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project. Stroke. 1994, 25: 333-337. 10.1161/01.STR.25.2.333.CrossRefPubMed Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow C: Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project. Stroke. 1994, 25: 333-337. 10.1161/01.STR.25.2.333.CrossRefPubMed
5.
go back to reference White CR, Brock TA, Chang LY, Crapo J, Briscoe P, Ku D, Bradley WA, Gianturco SH, Gore J, Freeman BA, et al: Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci U S A. 1994, 91: 1044-1048. 10.1073/pnas.91.3.1044.CrossRefPubMedPubMedCentral White CR, Brock TA, Chang LY, Crapo J, Briscoe P, Ku D, Bradley WA, Gianturco SH, Gore J, Freeman BA, et al: Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci U S A. 1994, 91: 1044-1048. 10.1073/pnas.91.3.1044.CrossRefPubMedPubMedCentral
6.
go back to reference Moncada S, Martin JF: Evolution of nitric oxide. Lancet. 1993, 341: 1511-10.1016/0140-6736(93)90641-S.CrossRefPubMed Moncada S, Martin JF: Evolution of nitric oxide. Lancet. 1993, 341: 1511-10.1016/0140-6736(93)90641-S.CrossRefPubMed
7.
go back to reference Fukai T, Folz RJ, Landmesser U, Harrison DG: Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc Res. 2002, 55: 239-249. 10.1016/S0008-6363(02)00328-0.CrossRefPubMed Fukai T, Folz RJ, Landmesser U, Harrison DG: Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc Res. 2002, 55: 239-249. 10.1016/S0008-6363(02)00328-0.CrossRefPubMed
8.
go back to reference Steg PG, Bhatt DL, Wilson PW, D'Agostino R, Ohman EM, Rother J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, et al: One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007, 297: 1197-1206. 10.1001/jama.297.11.1197.CrossRefPubMed Steg PG, Bhatt DL, Wilson PW, D'Agostino R, Ohman EM, Rother J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, et al: One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007, 297: 1197-1206. 10.1001/jama.297.11.1197.CrossRefPubMed
9.
go back to reference Purroy F, Coll B, Oro M, Seto E, Pinol-Ripoll G, Plana A, Quilez A, Sanahuja J, Brieva L, Vega L, Fernandez E: Predictive value of ankle brachial index in patients with acute ischaemic stroke. Eur J Neurol. 2010, 17: 602-606. 10.1111/j.1468-1331.2009.02874.x.CrossRefPubMed Purroy F, Coll B, Oro M, Seto E, Pinol-Ripoll G, Plana A, Quilez A, Sanahuja J, Brieva L, Vega L, Fernandez E: Predictive value of ankle brachial index in patients with acute ischaemic stroke. Eur J Neurol. 2010, 17: 602-606. 10.1111/j.1468-1331.2009.02874.x.CrossRefPubMed
10.
go back to reference Mukherjee D, Yadav JS: Carotid artery intimal-medial thickness: indicator of atherosclerotic burden and response to risk factor modification. Am Heart J. 2002, 144: 753-759.CrossRefPubMed Mukherjee D, Yadav JS: Carotid artery intimal-medial thickness: indicator of atherosclerotic burden and response to risk factor modification. Am Heart J. 2002, 144: 753-759.CrossRefPubMed
11.
go back to reference Bots ML, Grobbee DE: Intima media thickness as a surrogate marker for generalised atherosclerosis. Cardiovasc Drugs Ther. 2002, 16: 341-351. 10.1023/A:1021738111273.CrossRefPubMed Bots ML, Grobbee DE: Intima media thickness as a surrogate marker for generalised atherosclerosis. Cardiovasc Drugs Ther. 2002, 16: 341-351. 10.1023/A:1021738111273.CrossRefPubMed
12.
go back to reference Roquer J, Ois A, Rodriguez-Campello A, Gomis M, Munteis E, Jimenez-Conde J, Cuadrado-Godia E, Martinez-Rodriguez JE: Atherosclerotic burden and early mortality in acute ischemic stroke. Arch Neurol. 2007, 64: 699-704. 10.1001/archneur.64.5.699.CrossRefPubMed Roquer J, Ois A, Rodriguez-Campello A, Gomis M, Munteis E, Jimenez-Conde J, Cuadrado-Godia E, Martinez-Rodriguez JE: Atherosclerotic burden and early mortality in acute ischemic stroke. Arch Neurol. 2007, 64: 699-704. 10.1001/archneur.64.5.699.CrossRefPubMed
13.
go back to reference Syeda B, Gottsauner-Wolf M, Denk S, Pichler P, Khorsand A, Glogar D: Arterial compliance: a diagnostic marker for atherosclerotic plaque burden?. Am J Hypertens. 2003, 16: 356-362. 10.1016/S0895-7061(03)00037-2.CrossRefPubMed Syeda B, Gottsauner-Wolf M, Denk S, Pichler P, Khorsand A, Glogar D: Arterial compliance: a diagnostic marker for atherosclerotic plaque burden?. Am J Hypertens. 2003, 16: 356-362. 10.1016/S0895-7061(03)00037-2.CrossRefPubMed
14.
go back to reference Tsioufis C, Dimitriadis K, Antoniadis D, Stefanadis C, Kallikazaros I: Inter-relationships of microalbuminuria with the other surrogates of the atherosclerotic cardiovascular disease in hypertensive subjects. Am J Hypertens. 2004, 17: 470-476. 10.1016/j.amjhyper.2004.02.008.CrossRefPubMed Tsioufis C, Dimitriadis K, Antoniadis D, Stefanadis C, Kallikazaros I: Inter-relationships of microalbuminuria with the other surrogates of the atherosclerotic cardiovascular disease in hypertensive subjects. Am J Hypertens. 2004, 17: 470-476. 10.1016/j.amjhyper.2004.02.008.CrossRefPubMed
15.
go back to reference Willens HJ, Davis W, Herrington DM, Wade K, Kesler K, Mallon S, Brown WV, Reiber JH, Raines JK: Relationship of peripheral arterial compliance and standard cardiovascular risk factors. Vasc Endovascular Surg. 2003, 37: 197-206. 10.1177/153857440303700307.CrossRefPubMed Willens HJ, Davis W, Herrington DM, Wade K, Kesler K, Mallon S, Brown WV, Reiber JH, Raines JK: Relationship of peripheral arterial compliance and standard cardiovascular risk factors. Vasc Endovascular Surg. 2003, 37: 197-206. 10.1177/153857440303700307.CrossRefPubMed
17.
go back to reference Feron O, Dessy C, Desager JP, Balligand JL: Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. Circulation. 2001, 103: 113-118. 10.1161/01.CIR.103.1.113.CrossRefPubMed Feron O, Dessy C, Desager JP, Balligand JL: Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. Circulation. 2001, 103: 113-118. 10.1161/01.CIR.103.1.113.CrossRefPubMed
18.
go back to reference John S, Schlaich M, Langenfeld M, Weihprecht H, Schmitz G, Weidinger G, Schmieder RE: Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study. Circulation. 1998, 98: 211-216. 10.1161/01.CIR.98.3.211.CrossRefPubMed John S, Schlaich M, Langenfeld M, Weihprecht H, Schmitz G, Weidinger G, Schmieder RE: Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study. Circulation. 1998, 98: 211-216. 10.1161/01.CIR.98.3.211.CrossRefPubMed
19.
go back to reference Landmesser U, Engberding N, Bahlmann FH, Schaefer A, Wiencke A, Heineke A, Spiekermann S, Hilfiker-Kleiner D, Templin C, Kotlarz D, et al: Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase. Circulation. 2004, 110: 1933-1939. 10.1161/01.CIR.0000143232.67642.7A.CrossRefPubMed Landmesser U, Engberding N, Bahlmann FH, Schaefer A, Wiencke A, Heineke A, Spiekermann S, Hilfiker-Kleiner D, Templin C, Kotlarz D, et al: Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase. Circulation. 2004, 110: 1933-1939. 10.1161/01.CIR.0000143232.67642.7A.CrossRefPubMed
20.
go back to reference Wagner AH, Kohler T, Ruckschloss U, Just I, Hecker M: Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation. Arterioscler Thromb Vasc Biol. 2000, 20: 61-69. 10.1161/01.ATV.20.1.61.CrossRefPubMed Wagner AH, Kohler T, Ruckschloss U, Just I, Hecker M: Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation. Arterioscler Thromb Vasc Biol. 2000, 20: 61-69. 10.1161/01.ATV.20.1.61.CrossRefPubMed
21.
go back to reference Wassmann S, Laufs U, Muller K, Konkol C, Ahlbory K, Baumer AT, Linz W, Bohm M, Nickenig G: Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol. 2002, 22: 300-305. 10.1161/hq0202.104081.CrossRefPubMed Wassmann S, Laufs U, Muller K, Konkol C, Ahlbory K, Baumer AT, Linz W, Bohm M, Nickenig G: Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol. 2002, 22: 300-305. 10.1161/hq0202.104081.CrossRefPubMed
22.
go back to reference Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, et al: Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA. 2006, 295: 1556-1565. 10.1001/jama.295.13.jpc60002.CrossRefPubMed Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, et al: Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA. 2006, 295: 1556-1565. 10.1001/jama.295.13.jpc60002.CrossRefPubMed
23.
go back to reference Patel TN, Shishehbor MH, Bhatt DL: A review of high-dose statin therapy: targeting cholesterol and inflammation in atherosclerosis. Eur Heart J. 2007, 28: 664-672. 10.1093/eurheartj/ehl445.CrossRefPubMed Patel TN, Shishehbor MH, Bhatt DL: A review of high-dose statin therapy: targeting cholesterol and inflammation in atherosclerosis. Eur Heart J. 2007, 28: 664-672. 10.1093/eurheartj/ehl445.CrossRefPubMed
24.
go back to reference Wenzel P, Daiber A, Oelze M, Brandt M, Closs E, Xu J, Thum T, Bauersachs J, Ertl G, Zou MH, et al: Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus. Atherosclerosis. 2008, 198: 65-76. 10.1016/j.atherosclerosis.2007.10.003.CrossRefPubMed Wenzel P, Daiber A, Oelze M, Brandt M, Closs E, Xu J, Thum T, Bauersachs J, Ertl G, Zou MH, et al: Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus. Atherosclerosis. 2008, 198: 65-76. 10.1016/j.atherosclerosis.2007.10.003.CrossRefPubMed
25.
go back to reference Roquer J, Segura T, Serena J, Castillo J: Endothelial dysfunction, vascular disease and stroke: the ARTICO study. Cerebrovasc Dis. 2009, 27 (Suppl 1): 25-37.CrossRefPubMed Roquer J, Segura T, Serena J, Castillo J: Endothelial dysfunction, vascular disease and stroke: the ARTICO study. Cerebrovasc Dis. 2009, 27 (Suppl 1): 25-37.CrossRefPubMed
26.
go back to reference Moneta GL, Edwards JM, Chitwood RW, Taylor LM, Lee RW, Cummings CA, Porter JM: Correlation of North American Symptomatic Carotid Endarterectomy Trial (NASCET) angiographic definition of 70% to 99% internal carotid artery stenosis with duplex scanning. J Vasc Surg. 1993, 17: 152-157. discussion 157–159CrossRefPubMed Moneta GL, Edwards JM, Chitwood RW, Taylor LM, Lee RW, Cummings CA, Porter JM: Correlation of North American Symptomatic Carotid Endarterectomy Trial (NASCET) angiographic definition of 70% to 99% internal carotid artery stenosis with duplex scanning. J Vasc Surg. 1993, 17: 152-157. discussion 157–159CrossRefPubMed
27.
go back to reference de Bray JM, Baud JM, Delanoy P, Camuzat JP, Dehans V, Descamp-Le Chevoir J, Launay JR, Luizy F, Sentou Y, Cales P: Reproducibility in ultrasonic characterization of carotid plaques. Cerebrovasc Dis. 1998, 8: 273-277. 10.1159/000015865.CrossRefPubMed de Bray JM, Baud JM, Delanoy P, Camuzat JP, Dehans V, Descamp-Le Chevoir J, Launay JR, Luizy F, Sentou Y, Cales P: Reproducibility in ultrasonic characterization of carotid plaques. Cerebrovasc Dis. 1998, 8: 273-277. 10.1159/000015865.CrossRefPubMed
Metadata
Title
Oxidative stress markers are associated to vascular recurrence in non-cardioembolic stroke patients non-treated with statins
Authors
David Brea
Jaume Roquer
Joaquín Serena
Tomás Segura
José Castillo
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2012
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/1471-2377-12-65

Other articles of this Issue 1/2012

BMC Neurology 1/2012 Go to the issue